| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |